PATENT CLAIM ANALYSIS

Application Number: 16154294
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["424", "186100"]

Abstract:
Vaccination methods to control PCV2 infection with different PCV2 subtypes are disclosed. Specifically, a PCV2 subtype b (PCV2b) ORF2 proteins or immunogenic compositions comprising a PCV2b ORF2 protein are used in a method for the treatment or prevention of an infection with PCV2 of the same PCV2b and/or different subtype; the reduction, prevention or treatment of clinical signs caused by an infection with PCV2 of the same PCV2b or a different subtype; and/or the prevention or treatment of a disease caused by an infection with PCV2 of the same PCV2b and/or a different subtype. The present invention in particular relates to PCV2 subtype b (PCV2b) ORF2 proteins characterized in that they contain at least one mutation in the BC loop that such that the expressed protein is preferably expressed in a higher amount compared to a PCV2 ORF2 protein that does not contain such mutation.

Claim (Index 19):
A method of producing the polypeptide of  claim 1 , comprising infecting a cell with a baculovirus containing a polynucleotide encoding said polypeptide.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 2.26087
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14504839', '15295053', '15562167', '14917620', '13049364']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7655376158705582
- 35 USC 102 Novelty (BERT): 0.6790486598592343
- Combined Prediction Score: 0.7568887202694259
- Mean Citation Score: 536.554374
- Max Citation Score: 721.2888
- Similarity Product: 668.8324715742589

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test